CoChat

Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations

Open access
Ramlogan‐Steel, Charmaine A., Murali, Aparna, Andrzejewski, Slawomir, Dhungel, Bijay, Steel, Jason C., Layton, Christopher J. · 2019 · Clinical & Experimental Ophthalmology
Cited by 57

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Voretigene neparvovec‐rzyl was recently approved for the treatment of Leber congenital amaurosis, and the use of gene therapy for eye disease is attracting even greater interest. The eye has immune privileged status, is easily accessible, requires a reduced dosage of therapy due to its size and is highly compartmentalized, significantly reducing systemic spread. Adeno‐associated virus (AAV), with its low pathogenicity, prolonged expression profile and ability to transduce multiple cell types, has become the leading gene therapy vector. Target diseases have moved beyond currently untreatable inherited dystrophies to common, partially treatable acquired conditions such as exudative age‐related macular degeneration and glaucoma, but use of the technology in these conditions imposes added obligations for caution in vector design. This review discusses the current status of AAV gene therapy trials in genetic and acquired ocular diseases, and explores new scientific developments, which could help ensure effective and safe use of the therapy in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ceo.13416

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 121

  1. 10.1007/978-1-60761-938-3_5 · DOI · Paper page
  2. Daiger SP, 1998, Data services and software for identifying genes and mutations causing retinal degeneration, Invest. Ophthalmol. Vis. Sci., 39, S295
  3. 10.1016/j.preteyeres.2018.08.003 · DOI
  4. 10.1038/gt.2008.66 · DOI
  5. 10.1002/jcb.21819 · DOI
  6. Vincent KA, 1997, Analysis of recombinant adeno‐associated virus packaging and requirements for rep and cap gene products, J Virol, 71, 1897, 10.1128/jvi.71.3.1897-1905.1997 · DOI · Paper page
  7. 10.1136/bjo.2009.174912 · DOI · Paper page
  8. 10.1016/j.survophthal.2004.04.003 · DOI · Paper page
  9. Weleber RG, 1993, Leber Congenital Amaurosis
  10. 10.12998/wjcc.v3.i2.112 · DOI · Paper page
  11. 10.1093/hmg/ddu588 · DOI
  12. 10.1002/jgm.278 · DOI · Paper page
  13. 10.1073/pnas.1218933110 · DOI · Paper page
  14. 10.1038/sj.gt.3302861 · DOI · Paper page
  15. 10.1167/iovs.02-0595 · DOI · Paper page
  16. 10.1007/s10633-005-3159-0 · DOI
  17. 10.1016/j.ymthe.2005.08.008 · DOI · Paper page
  18. 10.1038/gt.2012.63 · DOI
  19. 10.1038/gt.2010.111 · DOI · Paper page
  20. 10.1089/hum.2013.146 · DOI · Paper page
  21. 10.1001/archophthalmol.2011.298 · DOI · Paper page
  22. 10.1016/j.ophtha.2016.03.003 · DOI · Paper page
  23. 10.1101/cshperspect.a017285 · DOI
  24. 10.1016/S0140-6736(17)31868-8 · DOI · Paper page
  25. 10.1056/NEJMoa1412965 · DOI · Paper page
  26. 2018, Voretigene neparvovec‐rzyl (Luxturna) for inherited retinal dystrophy, Med Lett Drugs Ther, 60, 53
  27. 10.1016/j.ophtha.2012.11.048 · DOI · Paper page
  28. 10.1097/APO.0000000000000227 · DOI
  29. 10.1093/hmg/9.4.645 · DOI · Paper page
  30. 10.1038/sj.gt.3302460 · DOI
  31. 10.1016/S1525-0016(03)00144-8 · DOI
  32. 10.1080/14712598.2018.1389886 · DOI
  33. 10.1167/iovs.12-11541 · DOI
  34. 10.1038/gt.2015.93 · DOI · Paper page
  35. MacDonald IM, 1993, Choroideremia
  36. 10.1371/journal.pone.0151943 · DOI
  37. 10.1016/j.ophtha.2009.01.016 · DOI
  38. Choroideremia KJ, 1986, A clinical and genetic study of 84 Finnish patients and 126 female carriers, Acta Ophthalmol Suppl, 176, 1
  39. 10.1016/S0161-6420(98)99031-5 · DOI
  40. 10.1586/14737159.4.4.478 · DOI
  41. 10.1016/j.ophtha.2016.10.022 · DOI
  42. 10.1073/pnas.051606598 · DOI · Paper page
  43. 10.1167/iovs.13-13454 · DOI · Paper page
  44. 10.1167/iovs.09-4892 · DOI
  45. 10.1016/S0161-6420(00)00643-6 · DOI
  46. 10.1002/jgm.2768 · DOI · Paper page
  47. 10.1126/scitranslmed.3002103 · DOI · Paper page
  48. 10.1136/bjophthalmol-2014-306505 · DOI · Paper page
  49. 10.1007/s12035-007-0025-y · DOI
  50. 10.1038/935 · DOI · Paper page
  51. 10.1093/hmg/9.14.2107 · DOI · Paper page
  52. 10.1086/341835 · DOI · Paper page
  53. 10.1073/pnas.0907720106 · DOI · Paper page
  54. 10.1016/j.ajhg.2012.07.006 · DOI · Paper page
  55. 10.1038/ng.3319 · DOI · Paper page
  56. 10.1038/sj.ejhg.5201269 · DOI · Paper page
  57. Fischer MD, 2016, Safe delivery of rAAV8.CNGA3 in patients with achromatopsia, Ophthalmologica, 236, 30
  58. 10.1038/nm1596 · DOI · Paper page
  59. 10.1136/bjo.79.7.697 · DOI · Paper page
  60. Rao P, 2018, Congenital X‐linked retinoschisis: an updated clinical review, Asia Pac J Ophthalmol (Phila)
  61. 10.1007/0-387-32442-9_39 · DOI
  62. 10.1038/gt.2009.61 · DOI
  63. 10.1086/346066 · DOI · Paper page
  64. 10.1038/sj.ejhg.5201828 · DOI · Paper page
  65. Yu‐Wai‐Man P, 1993, Leber Hereditary Optic Neuropathy
  66. 10.3109/08820538.2015.1115251 · DOI
  67. 10.1517/21678707.2015.1098531 · DOI
  68. 10.1001/archneur.62.5.730 · DOI · Paper page
  69. 10.1089/hum.2008.090 · DOI
  70. 10.1001/jamaophthalmol.2013.7971 · DOI · Paper page
  71. 10.1186/s40662-016-0063-5 · DOI · Paper page
  72. 10.1016/S2214-109X(13)70145-1 · DOI · Paper page
  73. 10.1155/2015/138070 · DOI · Paper page
  74. Weber BH, 2014, The role of the complement system in age‐related macular degeneration, Dtsch Arztebl Int, 111, 133
  75. 10.1016/j.molimm.2015.02.032 · DOI
  76. 10.1016/j.pop.2015.05.009 · DOI
  77. 10.1586/17512433.2015.990379 · DOI
  78. 10.1126/science.285.5425.245 · DOI · Paper page
  79. 10.1089/hum.2006.17.167 · DOI · Paper page
  80. 10.1016/S0002-9440(10)61697-5 · DOI
  81. 10.1002/jcp.1114 · DOI · Paper page
  82. 10.1126/science.286.5448.2244 · DOI · Paper page
  83. Mori K, 2002, AAV‐mediated gene transfer of pigment epithelium‐derived factor inhibits choroidal neovascularization, Invest Ophthalmol Vis Sci, 43, 1994
  84. 10.1007/978-1-4614-3209-8_86 · DOI
  85. 10.1371/journal.pone.0152589 · DOI
  86. 10.1089/hum.2006.088 · DOI · Paper page
  87. McClements ME, 2017, Adeno‐associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes, Yale J Biol Med, 90, 611
  88. 10.1038/gt.2013.3 · DOI · Paper page
  89. 10.1002/biot.201400529 · DOI
  90. Blacharski PA, 1988, Fundus flavimaculatus, 135
  91. 10.1371/journal.pone.0094272 · DOI · Paper page
  92. 10.1073/pnas.92.21.9815 · DOI · Paper page
  93. 10.1242/jcs.02636 · DOI · Paper page
  94. Udovichenko IP, 2002, Actin‐based motor properties of native myosin VIIa, J Cell Sci, 115, 445, 10.1242/jcs.115.2.445 · DOI · Paper page
  95. 10.1016/j.jmb.2009.03.047 · DOI
  96. 10.1038/jcbfm.2010.90 · DOI
  97. 10.1016/j.omtm.2017.04.008 · DOI
  98. 10.1073/pnas.95.7.3978 · DOI · Paper page
  99. 10.1073/pnas.91.5.1632 · DOI · Paper page
  100. 10.1038/sj.gt.3302791 · DOI · Paper page
  101. Pease ME, 2000, Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma, Invest Ophthalmol Vis Sci, 41, 764
  102. 10.1167/iovs.11-8484 · DOI
  103. 10.1073/pnas.1706193114 · DOI · Paper page
  104. 10.1038/gt.2011.142 · DOI
  105. 10.1038/eye.2000.126 · doi:10.1038/eye.2000.126
  106. 10.1186/s40662-015-0026-2 · DOI · Paper page
  107. Layton C, 2006, Aspects of Diabetic Retinal Neuropathy
  108. 10.1111/ceo.12795 · DOI
  109. 10.1016/j.pharmthera.2017.01.003 · DOI
  110. Danser AH, 1994, Angiotensin levels in the eye, Invest Ophthalmol Vis Sci, 35, 1008
  111. 10.1210/jcem-68-1-160 · DOI · Paper page
  112. 10.1038/jcbfm.2008.154 · doi:10.1038/jcbfm.2008.154
  113. 10.1038/mt.2011.155 · DOI · Paper page
  114. 10.1016/j.ajpath.2016.01.023 · DOI
  115. 10.1038/labinvest.2015.135 · DOI
  116. Ideno J, 2007, Prevention of diabetic retinopathy by intraocular soluble flt‐1 gene transfer in a spontaneously diabetic rat model, Int J Mol Med, 19, 75
  117. 10.1016/j.preteyeres.2018.01.004 · DOI
  118. 10.1371/journal.pone.0035318 · DOI
  119. 10.1038/srep22131 · DOI
  120. 10.1038/mt.2012.194 · DOI · Paper page
  121. 10.1038/nbt0315-217 · DOI

Cited by

See all 57

Metadata

Authors
Ramlogan‐Steel, C. A., Murali, A., Andrzejewski, S., Dhungel, B., Steel, J. C., & Layton, C. J.
Venue
Clinical & Experimental Ophthalmology
Publisher
Wiley
Published
2019-01-02
Volume
47
Issue
4
Pages
521-536
ISSN
  • 1442-6404 (ISSN-L)
  • 1442-9071
OpenAlex
W2897417813
Cited by
57
References
32
FWCI
4.03
Type
journal article
Language
en
Open access
green
Funders
Gallipoli Medical Research Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations. https://app.cochat.ai/papers/10.1111/ceo.13416
The paper
Ramlogan‐Steel, C. A., Murali, A., Andrzejewski, S., Dhungel, B., Steel, J. C., & Layton, C. J. (2019). Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.13416

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.